S.1096

Preserve Access to Affordable Generics and Biosimilars Act

The Preserve Access to Affordable Generics and Biosimilars Act aims to prevent brand name drug companies from compensating generic drug companies to delay the entry of generic drugs into the market. It also seeks to stop biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products. The Act enhances competition in the pharmaceutical market and supports antitrust law by prohibiting anticompetitive practices that harm consumers.